Dr. Stefanick’s research focuses on women’s health, chronic disease prevention and aging. She has conducted the large Women’s Health Initiative (WHI) randomized controlled trials (RCT) of menopausal hormone therapy, low-fat diet, and calcium & vitamin D on heart disease, cancer, osteoporotic fractures and dementia and is currently Principal Investigator (PI) of the WHI Extension Study, the WHI Strong & Healthy (WHISH) physical activity trial, focusing on heart disease, and the Osteoporotic Fractures in Men Study (MrOS). Dr. Stefanick is also founding Director of the Stanford Women’s Health and Sex Differences in Medicine (WHSDM, “wisdom”) Center and teaches courses on the role of sex and gender and sexuality in health over the life course and across the sexual and gender spectra.
Chronic Disease Prevention
Linda Giudice, UCSF
Yoel Sadovsky, UPMC
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health: